Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fromm

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
The Biochemical Journal|March 1, 1997
Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and speciesT Toida, H Yoshida, H Toyoda, et al.
Nature Medicine|August 1, 1997
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfateY Chen, T Maguire, R E Hileman, et al.
Circulation|April 6, 1999
Diagnostic marker cooperative study for the diagnosis of myocardial infarctionJ Zimmerman, R Fromm, D Meyer, et al.
American Journal of Clinical Pathology|June 10, 2026
CD48 expression in T-lymphoblastic leukemia/lymphoma and mature T-cell neoplasms: role in detecting measurable residual disease and potential confounders, a single-institution retrospective reviewAlireza Torabi, Jonathan R Fromm, Russell Dorer, et al.
Biochemistry|May 25, 1993
Nature of the interaction of heparin with acidic fibroblast growth factorH Mach, D B Volkin, C J Burke, et al.
Cytometry. Part B, Clinical Cytometry|November 13, 2018
Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1Yi Zhou, Andres Moon, Eric Hoyle, et al.
British Journal of Haematology|December 29, 2018
A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeksJacqueline N Poston, Jonathan R Fromm, Heather A Rasmussen, et al.
American Journal of Clinical Pathology|August 31, 2021
Clinicopathologic Findings in Patients With Initial Diagnosis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Colorectal MucosaLorinda A Soma, Stephen D Smith, Prathima Reddy, et al.
Genes, Chromosomes & Cancer|December 10, 2015
Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphomaStephen J Salipante, Andrew Adey, Anju Thomas, et al.
Bone Marrow Transplantation|February 27, 2019
Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remissionColin D Godwin, Jonathan R Fromm, Megan Othus, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
The Biochemical Journal|March 1, 1997
Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and speciesT Toida, H Yoshida, H Toyoda, et al.
Nature Medicine|August 1, 1997
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfateY Chen, T Maguire, R E Hileman, et al.
Circulation|April 6, 1999
Diagnostic marker cooperative study for the diagnosis of myocardial infarctionJ Zimmerman, R Fromm, D Meyer, et al.
American Journal of Clinical Pathology|June 10, 2026
CD48 expression in T-lymphoblastic leukemia/lymphoma and mature T-cell neoplasms: role in detecting measurable residual disease and potential confounders, a single-institution retrospective reviewAlireza Torabi, Jonathan R Fromm, Russell Dorer, et al.
Biochemistry|May 25, 1993
Nature of the interaction of heparin with acidic fibroblast growth factorH Mach, D B Volkin, C J Burke, et al.
Cytometry. Part B, Clinical Cytometry|November 13, 2018
Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1Yi Zhou, Andres Moon, Eric Hoyle, et al.
British Journal of Haematology|December 29, 2018
A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeksJacqueline N Poston, Jonathan R Fromm, Heather A Rasmussen, et al.
American Journal of Clinical Pathology|August 31, 2021
Clinicopathologic Findings in Patients With Initial Diagnosis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) in Colorectal MucosaLorinda A Soma, Stephen D Smith, Prathima Reddy, et al.
Genes, Chromosomes & Cancer|December 10, 2015
Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphomaStephen J Salipante, Andrew Adey, Anju Thomas, et al.
Bone Marrow Transplantation|February 27, 2019
Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remissionColin D Godwin, Jonathan R Fromm, Megan Othus, et al.
Pageof 11